Original Article
Evaluation of the anti-tumor activity of histone deacetylase inhibitors (HDAC6) on human pancreatic adenocarcinoma (PANC-1) cell line using a zebrafish xenograft model
Precision Cancer Medicine
2024;
6:
5
(30 September 2024)
Case Report
Safe management of 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) + panitumumab in a patient with metastatic colorectal cancer undergoing hemodialysis for bilateral nephrectomy: a case report
Precision Cancer Medicine
2024;
6:
4
(30 September 2024)
Review Article
NTRK1/2/3: biology, detection and therapy
Precision Cancer Medicine
2024;
6:
3
(30 September 2024)
Review Article
ALK fusions turn sixteen in lung cancer: a review on their biology, detection and therapy
Precision Cancer Medicine
2024;
6:
2
(30 September 2024)
Review Article
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions
Precision Cancer Medicine
2024;
6:
1
(30 September 2024)
Editorial Commentary
Quality assurance in thoracic oncology: the surgeon’s perspective
Precision Cancer Medicine
2023;
6:
20
(30 June 2023)
Case Report
Locally advanced HPV-positive oropharyngeal cancer cured with single agent pembrolizumab in a patient using cannabis: a case report
Precision Cancer Medicine
2023;
6:
19
(30 June 2023)
Case Report
A challenge in emergency department: a case report of oxaliplatin-induced Kounis syndrome
Precision Cancer Medicine
2023;
6:
18
(30 June 2023)
Case Report
A case report of EGFR L861Q mutation in synchronous de novo small cell and non-small cell lung cancer: molecular interrogation identifies origin and potential options for targeted therapy
Precision Cancer Medicine
2023;
6:
17
(30 June 2023)
Case Report
Pathologically documented brain necrosis: response to bevacizumab after irradiation for solitary fibrous tumour/haemangiopericytoma: case report and literature review
Precision Cancer Medicine
2023;
6:
16
(30 June 2023)
Review Article
NRG1 fusions in non-small cell lung cancer: a narrative review on biology, detection and therapy
Precision Cancer Medicine
2023;
6:
15
(30 June 2023)
Review Article
Microsatellite instability and immunotherapy in gastric cancer: a narrative review
Precision Cancer Medicine
2023;
6:
14
(30 June 2023)
Review Article
Extracellular vesicles long RNA for cancer diagnosis and prognosis: a narrative review
Precision Cancer Medicine
2023;
6:
13
(30 June 2023)
Editorial
A quality assurance program: a clear necessity in modern oncology care
Precision Cancer Medicine
2023;
6:
12
(30 June 2023)
Editorial
Choice of first-line anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) based on the results of a systematic review and network meta-analysis
Precision Cancer Medicine
2023;
6:
11
(30 June 2023)
Case Report
The role of concurrent amplification of PD-L1, PD-L2 and JAK2 in metastatic lung adenocarcinoma as a biomarker of immune checkpoint inhibitor response: a case report
Precision Cancer Medicine
2023;
6:
10
(30 March 2023)
Case Report
Endoscopic endonasal removal of nasal cavity chondrosarcoma extending to the base of the skull: a case report
Precision Cancer Medicine
2023;
6:
9
(30 March 2023)
Review Article
Radiotherapy in non-surgical management of esophageal cancer in the era of immuno-oncology: a narrative review
Precision Cancer Medicine
2023;
6:
8
(30 March 2023)
Review Article
The use of 18F-FDG PET/CT for radiotherapy treatment planning in non-small cell lung cancer: a mini-review
Precision Cancer Medicine
2023;
6:
7
(30 March 2023)
Review Article
Emerging drivers in non-small cell lung cancer, is there a role for immunotherapy?—a narrative review
Precision Cancer Medicine
2023;
6:
6
(30 March 2023)
Review Article
Lung cancer surgery in women: focus on gender-related outcomes—a narrative review
Precision Cancer Medicine
2023;
6:
5
(30 March 2023)
Review Article
Favouring quality improvement initiatives: the experience of the Belgian College of Radiation Oncology
Precision Cancer Medicine
2023;
6:
4
(30 March 2023)
Original Article
First-line ALK inhibitors in treatment-naive advanced ALK rearranged non-small cell lung cancer: systematic review and network meta-analysis
Precision Cancer Medicine
2023;
6:
3
(30 March 2023)
Editorial
Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality
Precision Cancer Medicine
2023;
6:
2
(30 March 2023)
Editorial
Utility of intraparenchymal blood patch testing following CT-guided lung biopsy
Precision Cancer Medicine
2023;
6:
1
(30 March 2023)
Case Report
Gonadotropin releasing hormone agonist-related meningioma progression causing abducens nerve palsy: an oncological case report
Precision Cancer Medicine
2022;
5:
40
(30 December 2022)
Review Article
Immune microenvironment and immunotherapy in pancreatic cancer: a narrative review
Precision Cancer Medicine
2022;
5:
39
(30 December 2022)
Review Article
The importance of standardized treatment planning and decision-making in radiation oncology for non-small-cell lung cancer—are current guidelines sufficiently strict for uniform target delineation?—a narrative literature review
Precision Cancer Medicine
2022;
5:
38
(30 December 2022)
Review Article
Applications of generative adversarial networks (GANs) in radiotherapy: narrative review
Precision Cancer Medicine
2022;
5:
37
(30 December 2022)
Study Protocol
Protocol: screening of genetic susceptibility genes for breast cancer patients and establishment of genetic high-risk populations cohort in east china communities
Precision Cancer Medicine
2022;
5:
36
(30 December 2022)
Original Article
Cancer incidence and mortality in Shanghai: rates in 2016 and trends from 2002 to 2016
Precision Cancer Medicine
2022;
5:
35
(30 December 2022)
Original Article
Tract injection of autologous blood (intraparenchymal blood patching) in percutaneous transthoracic CT-guided lung biopsy and the incidence of pneumothorax: a retrospective analysis
Precision Cancer Medicine
2022;
5:
34
(30 December 2022)
Expert Consensus
Chinese expert consensus recommendations for management of bone health in female patients with early breast cancer (2022 edition)
Precision Cancer Medicine
2022;
5:
33
(30 December 2022)
Editorial
Introduction to Management of Triple Negative Breast Cancer
Precision Cancer Medicine
2022;
5:
32
(30 December 2022)
Editorial
Neuroimaging aspects and clinical significance of giant perivascular spaces in the brain
Precision Cancer Medicine
2022;
5:
31
(30 December 2022)
Editorial Commentary
Uncommon EGFR mutations in non-small-cell lung cancer
Precision Cancer Medicine
2022;
5:
30
(30 September 2022)
Case Report
Giant perivascular spaces in brain: case report with a comprehensive literature review
Precision Cancer Medicine
2022;
5:
29
(30 September 2022)
Case Report
Sporadic mesenteric desmoid-type fibromatosis with “double-hit” T41A and S45P beta-catenin mutation profile: a case report of an extremely rare event—clinically relevant or much ado about nothing?
Precision Cancer Medicine
2022;
5:
28
(30 September 2022)
Review Article
Moving through rare lung cancer histologies: a narrative review on diagnosis and treatment of selected infrequent entities
Precision Cancer Medicine
2022;
5:
27
(30 September 2022)
Review Article
Review: biological implications of oncogenic rearrangements in non-small cell lung cancer
Precision Cancer Medicine
2022;
5:
26
(30 September 2022)
Review Article
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review
Precision Cancer Medicine
2022;
5:
25
(30 September 2022)
Review Article
Clinical implications of liquid biopsies in urogenital tumors: a narrative review
Precision Cancer Medicine
2022;
5:
24
(30 September 2022)
Review Article
A narrative review of epidemiology and prevention of lung cancer: sex/gender differences?
Precision Cancer Medicine
2022;
5:
23
(30 September 2022)
Editorial
How should clinicians manage metastatic non-small cell lung cancer patients with BRAF non-V600E mutations?
Precision Cancer Medicine
2022;
5:
21
(30 September 2022)
Case Report
RET-mutated non-small cell lung cancer treated with pralsetinib: a case series
Precision Cancer Medicine
2022;
5:
20
(30 June 2022)
Case Report
Ineffective target therapy in non-small cell lung cancer harboring BRAF G466R mutation: a case report and biological rationale
Precision Cancer Medicine
2022;
5:
19
(30 June 2022)
Case Report
KRAS G12V mutation as an acquired resistance mechanism after treatment with dabrafenib and trametinib in non-small cell lung cancer harbouring the BRAF V600E mutation: a case report
Precision Cancer Medicine
2022;
5:
18
(30 June 2022)
Review Article
Current evidence of BRCA mutations in genitourinary and gynecologic tumors: a scoping review
Precision Cancer Medicine
2022;
5:
17
(30 June 2022)
Review Article
The role of digital and integrative pathology for the detection of translocations: a narrative review
Precision Cancer Medicine
2022;
5:
16
(30 June 2022)